| Case definition and phenotype standardization in drug‐induced liver injury GP Aithal, PB Watkins, RJ Andrade, D Larrey, M Molokhia, H Takikawa, ... Clinical Pharmacology & Therapeutics 89 (6), 806-815, 2011 | 1162 | 2011 |
| Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease AC Mackey, L Green, L Liang, P Dinndorf, M Avigan Journal of pediatric gastroenterology and nutrition 44 (2), 265-267, 2007 | 549 | 2007 |
| A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. R Duncan, L Bazar, G Michelotti, T Tomonaga, H Krutzsch, M Avigan, ... Genes & development 8 (4), 465-480, 1994 | 397 | 1994 |
| Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. M Takimoto, T Tomonaga, M Matunis, M Avigan, H Krutzsch, G Dreyfuss, ... Journal of Biological Chemistry 268 (24), 18249-18258, 1993 | 297 | 1993 |
| High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening AM Axelrad, DE Fleischer, AJ Geller, CC Nguyen, JH Lewis, FH Al-Kawas, ... GASTROENTEROLOGY-BALTIMORE THEN PHILADELPHIA- 110, 1253-1258, 1996 | 223 | 1996 |
| Hepatotoxicity of immune checkpoint inhibitors: an evolving picture of risk associated with a vital class of immunotherapy agents DL Suzman, L Pelosof, A Rosenberg, MI Avigan Liver International 38 (6), 976-987, 2018 | 202 | 2018 |
| Randomized trial of chlorambucil for primary biliary cirrhosis JH Hoofnagle, GL Davis, DF Schafer, M Peters, MI Avigan, SC Pappas, ... Gastroenterology 91 (6), 1327-1334, 1986 | 172 | 1986 |
| Delivery of c-myc Antisense Phosphorothioate Oligodeoxynucleotides to Hematopoietic Cells in Culture by Liposome Fusion: Specific Reduction in c-myc Protein … SL Loke, C Stein, X Zhang, M Avigan, J Cohen, LM Neckers Mechanisms in B-Cell Neoplasia 1988: Workshop at the National Cancer …, 1988 | 168 | 1988 |
| A short course of prednisolone in chronic type B hepatitis: report of a randomized, double-blind, placebo-controlled trial JAYH HOOFNAGLE, GL DAVIS, SC PAPPAS, RG HANSON, M PETERS, ... Annals of internal medicine 104 (1), 12-17, 1986 | 168 | 1986 |
| Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients N Kothary, IL Diak, A Brinker, S Bezabeh, M Avigan, G Dal Pan Journal of the American Academy of Dermatology 65 (3), 546-551, 2011 | 167 | 2011 |
| Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update AC Mackey, L Green, C Leptak, M Avigan Journal of pediatric gastroenterology and nutrition 48 (3), 386-388, 2009 | 153 | 2009 |
| A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. MI Avigan, B Strober, D Levens Journal of Biological Chemistry 265 (30), 18538-18545, 1990 | 150 | 1990 |
| Using controlled clinical trials to learn more about acute drug‐induced liver injury PB Watkins, PJ Seligman, JS Pears, MI Avigan, JR Senior Hepatology 48 (5), 1680-1689, 2008 | 141 | 2008 |
| Telithromycin‐associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases AD Brinker, RT Wassel, J Lyndly, J Serrano, M Avigan, WM Lee, LB Seeff Hepatology 49 (1), 250-257, 2009 | 120 | 2009 |
| Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States MI Avigan, RP Mozersky, LB Seeff International journal of molecular sciences 17 (3), 331, 2016 | 118 | 2016 |
| Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab A Raval, G Akhavan-Toyserkani, A Brinker, M Avigan Annals of Internal Medicine 147 (10), 699-702, 2007 | 105 | 2007 |
| Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components J Farkas, A Angel, MI Avigan Journal of lipid research 14 (3), 344-356, 1973 | 93 | 1973 |
| Clinically significant liver injury in patients treated with natalizumab S Bezabeh, CM Flowers, C Kortepeter, M Avigan Alimentary pharmacology & therapeutics 31 (9), 1028-1035, 2010 | 88 | 2010 |
| Targeted Melting and Binding of a DNA Regulatory Element by a Transactivator of c-myc (∗) L Bazar, D Meighen, V Harris, R Duncan, D Levens, M Avigan Journal of Biological Chemistry 270 (14), 8241-8248, 1995 | 74 | 1995 |
| Treatment of chronic delta hepatitis with recombinant human alpha interferon J Hoofnagle, K Mullen, M Peters, M Avigan, Y Park, J Waggoner, J Gerin, ... Progress in clinical and biological research 234, 291-298, 1987 | 70 | 1987 |
